Yanhong Deng

Title: Yanhong Deng: Innovator in Colorectal Cancer Treatment

Introduction

Yanhong Deng is a prominent inventor based in Guangdong, China. She has made significant contributions to the field of oncology, particularly in the treatment of colorectal cancer. Her innovative work has led to the development of a pharmaceutical composition that shows promise in treating locally advanced mismatch repair-proficient/microsatellite stable (pMMR/MSS) colorectal cancer.

Latest Patents

Yanhong Deng holds a patent for a pharmaceutical composition aimed at treating locally advanced pMMR/MSS colorectal cancer. The patent details a combination of mFOLFOX6, bevacizumab, and a PD-1 inhibitor. Experimental results indicate that this composition has achieved major pathological remission in 14 out of 18 cases, with a complete pathological response in 10 cases. The treatment has demonstrated a significant reduction in tumor marker levels and has been noted for its safety and efficacy, with no fatal serious adverse events reported.

Career Highlights

Yanhong Deng is affiliated with The Sixth Affiliated Hospital, Sun Yat-Sen University. Her work in this institution has been pivotal in advancing cancer treatment methodologies. She has dedicated her career to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Yanhong Deng has collaborated with notable colleagues, including Fengyun Pei and Jun Huang. These partnerships have contributed to the successful development and testing of her patented pharmaceutical composition.

Conclusion

Yanhong Deng's contributions to the field of colorectal cancer treatment exemplify the impact of innovative research in medicine. Her patented pharmaceutical composition represents a significant advancement in the fight against cancer, showcasing her dedication to improving patient care.